Clin Osteol 2017; 22(3): 109-112

Fracture Liaison Service as a possible tool for improving care-evaluation of proximal femoral fractures and frequency of densitometry examination in Klatovy Hospital duruing 2012-2016Original contributions

P. Lukáš, M. Švagr, R. Pikner

We evaluated 350 (105 men and 245 women) hospitalized patients with a diagnosis of femoral neck fractures or pertro­ chanteric fractures at orthopedic department during period 2012-2016in Klatovska Hospital. Densitometric examination (DXA scan) was performed in only 21.4 % of all patients and only in 9.1 % patients after the fracture. Active osteoporotic treatment used 4.9 % patients before fracture and 8.6 % after the fracture. Treatment did not received of 97.1 % of patients without any DXA scan, 91.2 % of patients who had a DXA scan before the fracture, and 30.0 % of patients who had DXA scan after fracture. Patients who have underwent DXA scan after the fracture were more likely to be treated appropria­ tely. The introduction of Fracture Liaison Services, its ongoing evaluation, and improvement is a good way to increase the percentage of patients treated after severe osteoporotic fractures.

Keywords: hipfracture, bone densitometry, Fracture Liaison Service

Published: December 11, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lukáš P, Švagr M, Pikner R. Fracture Liaison Service as a possible tool for improving care-evaluation of proximal femoral fractures and frequency of densitometry examination in Klatovy Hospital duruing 2012-2016. Osteologický bulletin. 2017;22(3):109-112.
Download citation

References

  1. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteopor Int 2013;24:23-57. Go to original source...
  2. Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J et al. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteopor 2013;8:137. Go to original source...
  3. Capture the Fracture Educational Slide Kit Set, Part 1: The need for se­ condary fracture prevention, slides 5-7, downloaded october 2017. http://www.capturethefracture.org/slide-kits-reports
  4. Center JR, Bliuc D, Nguyen TV, Eisman JA Risk of Subsequent Fracture After Low-Trauma Fracture in Men and Women. JAMA 2007;297:387-394. Go to original source...
  5. Akesson K, Marsch D, Mitchell PJ et al. Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fractu­ re cycle. Osteoporos Int 2013; 24:2135. Go to original source...
  6. Marsh D, Akesson K, Beaton DE et al. Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 2011;22:2051. Go to original source...
  7. Štěpán JJ, Vaculík J, Palička V, Dungl P, Vyskočil V, Pavelka K. Péče o pacienty s nízkotraumatickou zlomeninou horního konce stehenní kosti. II. Následná osteologická péče. Osteol Bull 2015;20:46-56.
  8. Rosa J, Blahoš J, Bayer M, Broulík P et al. Osteoporóza u mužů, Stanovisko Společnosti pro metabolická onemocnění skeletu České lé­ kařské společnosti Jana Evangelisty Purkyně (SMOS ČLS JEP). Osteol Bull 2016;21:42-48.
  9. Rosa J, Šenk F, Palička V et al. Diagnostika a léčba postmenopauzální osteoporózy, Stanovisko Společnosti pro metabolická onemocnění ske­ letu ČLS JEP 2015; postup 2015. http://smos.cz/doporucene-postupy/Doporučený
  10. Jennings LA, Auerbach AD, Maselli J, Pekow PS, Lindenauer PK, Lee SJ. Missed Opportunities for Osteoporosis Treatment in Patients Hospitalized for Hip Fracture. J Am Geriat Soc 2010;58:650-657. Go to original source...
  11. Mendis AS, Ganda K, Seibel MJ. Barriers to secondary fracture pre­ vention in primary care. Osteoporos Int 2017; doi: 10.1007/s00198-0174131-z. [Epub ahead of print] Go to original source...
  12. Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE, McLellan A et al. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Min Res 2012;27:2039-2046. Go to original source...




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.